Sleep deprivation is reaching epidemic proportions in the U.S. and a serious problem for millions of Americans. Among those who suffer the most are the estimated 12 million people who have Willis-Ekbom Disease, more commonly known as Restless Legs Syndrome (RLS). Recently, the FDA approved the first and only NON-drug solution for people with RLS: Relaxis. Joining us to discuss this solution is Dr. Mark Buchfuhrer, Medical Director of the Southern California Restless Leg Syndrome Support Group.
